Targets & Screening

Discover the newest advances in target identification and screening, featuring expert insights and innovative technologies driving precision drug discovery – all in one comprehensive resource.

The Power of Myxobacteria-Derived Small Molecule Libraries

Patient-Derived Tumoroids for Precision Medicine and Drug Development

From Static to Dynamic: New Frontiers in Functional CRISPR Screens

Stabilising Membrane Proteins for Hit Identification and Drug Discovery

DRUG-seq: A High Throughput, Cost-Effective, and Unbiased Solution for Compound Screening

Harnessing Phage Display for Peptide and Antibody Discovery and Development

Causal Influence: Overcoming Clinical Development Challenges for CNS Drugs

Accelerate Drug Discovery with High Dimensional Multiomics

A Novel Modality For Unlocking The Hard To Drug Proteome

The Way Forward for Drug Discovery

Targeting DJ-1 to Transform Parkinson’s Therapy

Target Identification In Precision Models Of Heart Failure

Reconsidering the ‘Undruggable’ and Breaking the Rules of Drug Discovery

Powerful PROTACs

Inside GSK’s Direct-to-Biology Platform

Using AI/ML Tools to Translate from Target ID to the Clinic

Precision Targeting with Arrayed CRISPR

Syngenta’s Biological Breakthroughs

High Throughput Workflow For Compound Profiling Using Patient-Derived Organoids

3D Human Cardiac Models for HFpEF and Target Validation

Fusing JUMP Cell Painting with Orthogonal Data for Better Hit Discovery

Phenotypic Screening Uncovers Protein Degraders for Neurodegeneration